
Adicif S 1000mg/500mg Injection
Marketer
Cian Health Care Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Adicif S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection is a dual-action antibiotic solution indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration must be strictly under a physician's guidance. Consistent adherence to the prescribed dosage schedule is crucial; prematurely halting treatment compromises its effectiveness. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek emergency care for allergic reactions (skin rashes, itching, edema, respiratory distress). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals require physician approval before use. Alcohol consumption should be avoided due to potential synergistic drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and ample hydration contribute to faster recovery. Monitoring of the medication's effects may involve laboratory and diagnostic assessments.
Uses of Adicif S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Adicif S 1000mg/500mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Adicif S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Adicif S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Adicif S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Adicif S 1000mg/500mg Injection, offer a dual antibiotic approach. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent use of Adicif S 1000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Adicif S (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, research involving human subjects is scarce.
Breast feedingCAUTION
The administration of Adicif S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Adicif S 1000mg/500mg Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Adicif S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The use of Adicif S 1000mg/500mg Injection requires careful monitoring in individuals with advanced hepatic impairment. Dosage modification of Adicif S 1000mg/500mg Injection may be necessary; physician consultation is advised. Altering the dose of Adicif S 1000mg/500mg Injection is generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Adicif S 1000mg/500mg Injection :
Omitting a scheduled dose of Adicif S 1000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Adicif S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-infective agents |
